Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Colorectal Neoplasms × Radiosurgery × Clear all

Phase

Phase 2 9 Phase NA 3 Phase 1 3 Phase 3 2 Phase 1/2 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3 Carcinoma, Hepatocellular 2 Stomach Neoplasms 1 Pancreatic Adenocarcinoma 1 Pain 1 Neoplasm Metastasis 1 NSCLC 1 Colorectal Neoplasms 1 Castration-resistant Prostate Cancer Patients with Oligometastases 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Oxaliplatin 12 Fluorouracil 12 Bevacizumab 10 Leucovorin 9 Folfox protocol 7 Capecitabine 6 Irinotecan 5 IFL protocol 4 Cetuximab 4 Folic Acid 3 Aspirin 3 XELOX 2 Surgical Procedures, Operative 2 Magnetic Resonance Spectroscopy 2 Drug Therapy 2 trifluridine tipiracil drug combination 1 trametinib 1 titanium silicide 1 sulindac sulfone 1 spartalizumab 1 sacituzumab govitecan 1 regorafenib 1 folfirinox 1 dabrafenib 1 cobimetinib 1 cediranib 1 atezolizumab 1 aflibercept 1 Water 1 Vitamin B 6 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06185556 2024-08-23

COLDFIRE-III

Amsterdam UMC, location VUmc

Phase 2/3 Recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡